A threshold model for the susceptibility to transfusion-related acute lung injury

Transfusion Clinique et Biologique

Volumn 19, Issue 3, 2012, Pages 109-116

  Sachs, U J ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Pulmonary endothelium; Threshold model; TRALI; Transfusion related risk factors

Indexed keywords

CD40 LIGAND; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; REACTIVE OXYGEN METABOLITE;

ANTIBODY PRODUCTION; ARTICLE; BLOOD TRANSFUSION; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; HUMAN; HYPOXEMIA; LIVER FAILURE; LUNG EDEMA; LUNG ENDOTHELIUM; LUNG GAS EXCHANGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PLASMA TRANSFUSION; RESPIRATORY DISTRESS; RISK FACTOR; SEPSIS; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE LUNG INJURY; BLOOD TRANSFUSION; DISEASE SUSCEPTIBILITY; HUMANS; MODELS, BIOLOGICAL;

EID: 84864753280     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2012.03.003     Document Type: Article

References (70)

1. Barnard R.D. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. NY State J Med 1951, 51:2399-2402.
2. Popovsky M.A., Abel M.P., Moore S.B. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983, 128:185-189.
3. Popovsky M.A., Moore S.B. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985, 25:573-577.
4. SHOT summaries and reports [homepage on the internet]. Available from: (last accessed on Feb 22, 2012). http://www.shotuk.org/home/.
5. Bux J., Sachs U.J. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007, 136:788-799.
6. Zupanska B., Uhrynowska M., Konopka L. Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmale nocturnal hemoglobinuria. Transfusion 1999, 39:944-947.
7. Moore S.B. Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. Crit Care Med 2006, 34:S114-S117.
8. European Haemovigllance network: Definition of adverse transfusion events. Available from (last accessed on Nov 10, 2011). http://www.ehn-org.net/.
9. Kleinman S., Caulfield T., Chan P., Davenport R., McFarland J., McPhedran S., et al. Towards an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004, 44:1774-1789.
10. Bux J. Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang 2011, 100:122-128.
11. Vlaar A.P., Binnekade J.M., Prins D., van Stein D., Hofstra J.J., Schultz M.J., et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med 2010, 38:771-778.
12. Kernoff P.B., Durrant I.J., Rizza C.R., Wright F.W. Severe allergic pulmonary oedema after plasma transfusion. Br J Haematol 1972, 23:777-781.
13. Wolf C.F., Canale V.C. Fatal pulmonary hypersensitivity reaction to HL-A incompatible blood transfusion: report of a case and review of the literature. Transfusion 1976, 16:135-140.
14. Silliman C.C., Paterson A.J., Dickey W.O., Stroneck D.F., Popovsky M.A., Caldwell S.A., et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997, 37:719-726.
15. Flury R., Reutter F. Lethal anaphylactic shock during the transfusion of a thrombocyte concentrate. Schweiz Med Wochenschr 1966, 96:918-920.
16. Felbo M., Jensen K.G. Death in childbirth following transfusion of leukocyte-incompatible blood. Acta Haematol 1962, 27:113-119.
17. Dry S.M., Bechard K.M., Milford E.L., Churchill W.H., Benjamin R.J. The pathology of transfusion-related acute lung injury. Am J Clin Pathol 1999, 112:216-221.
18. Looney M.R., Su X., Van Ziffle J.A., Lowell C.A., Matthay M.A. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006, 116:1615-1623.
19. Kelher M.R., Masuno T., Moore E.E., Damle S., Meng X., Song Y., et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009, 113:2079-2087.
20. Sachs U.J., Wasel W., Bayat B., Bohle R.M., Hattar K., Berghöfer H., et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 2011, 117:669-677.
21. Silliman C.C., Voelkel N.F., Allard J.D., Elzi D.J., Tuder R.M., Johnson J.L., et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998, 101:1458-1467.
22. Fung Y.L., Silliman C.C. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev 2009, 23:266-283.
23. Silliman C.C., Curtis B.R., Kopko P.M., Khan S.Y., Kelher M.R., Schuller R.M., et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007, 109:1752-1755.
24. Johnson A., Phillips P., Hocking D., Tsan M.F., Ferro T. Protein kinase inhibitor prevents pulmonary oedema in response to H2O2. Am J Physiol 1989, 256:H1012-H1022.
25. Barnard M.L., Matalon S. Mechanisms of extracellular reactive oxygen species injury to the pulmonary microvasculature. J Appl Physiol 1992, 72:1724-1729.
26. Seeger W., Hansen T., Rössig R., Schmehl T., Schütte H., Krämer H.J., et al. Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability - effect of adenylate cyclase stimulation and phosphodiesterase inhibition. Microvasc Res 1995, 50:1-17.
27. Sachs U.J., Hattar K., Weissmann N., Bohle R.M., Siblelius U., Bux J. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury. Blood 2006, 107:1217-1219.
28. Bayat B., Tjahjono Y., Akylbek S., Hippenstiel S., Weissmann N., Sachs U.J., et al. Lung endothelial injury induced by HNA-3a antibodies in TRALI. Blood 2011, 118:40. [ASH Annual Meeting Abstract].
29. Strait R.T., Hicks W., Barasa N., Mahler A., Khodoun M., Köhl J., et al. MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med 2011, 208:2525-2544.
30. Looney M.R., Nguyen J.X., Hu Y., Van Ziffle J.A., Lowell C.A., Matthay M.A. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009, 119:3450-3461.
31. Finlayson J., Grey D., Kavangh L., Witt C. Transfusion-related acute lung injury in a neutropenic patient. Intern Med J 2011, 41:638-641.
32. Mangalmurti N.S., Xiong Z., Hulver M., Ranganathan M., Liu X.H., Oriss T., et al. Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood 2009, 113:1158-1166.
33. Fung Y.L., Kim M., Tabuchi A., Aslam R., Speck E.R., Chow L., et al. Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury. Blood 2010, 116:3073-3079.
34. Davis A., Mandal R., Johnson M., Makar R., Stowell C., Dzik S. A touch of TRALI. Transfusion 2008, 48:541-545.
35. Flesch B.K., Petershofen E.K., Bux J. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine. Tissue Antigens 2011, 78:1-7.
36. Eder A.F., Herron R., Strupp A., Dy B., Notari E.P., Chambers L.A., et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007, 47:599-607.
37. Gajic O., Rana R., Winters J.L., Yilmaz M., Mendez J.L., Rickman O.B., et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007, 176:886-891.
38. Vlaar A.P., Hofstra J.J., Determann R.M., Veelo D.P., Paulus F., Kulik W., et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011, 117:4218-4425.
39. Toy P., Gajic O., Bacchetti P., Looney M.R., Gropper M.A., Hubmayr R., et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012, 119:1757-1767.
40. Seeger W., Schneider U., Kreusler B., von Witzleben E., Walmrath D., Grimminger F., et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990, 76:1438-1444.
41. Vlaar A.P., Wolthuis E.K., Hofstra J.J., Roelofs J.J., Boon L., Schultz M.J., et al. Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies. Intensive Care Med 2010, 36:879-887.
42. Tung J.P., Fung Y.L., Nataatmadja M., Colebourne K.I., Esmaeel H.M., Wilson K., et al. A novel in vivo ovine model of transfusion-related acute lung injury (TRALI). Vox Sang 2011, 100:219-230.
43. Nicholson S.E., Johnson R.A., Craig T., Myers J.G., Durante W., Stewart R.M., et al. Transfusion-related acute lung injury in a rat model of trauma-hemorrhage. J Trauma 2011, 70:466-471.
44. Middelburg R.A., van Stein D., Zupanska B., Uhrynowska M., Gajic O., Muñiz-Diaz E., et al. Female donors and transfusion-related acute lung injury: a case-referent study from the International TRALI Unisex Research Group. Transfusion 2010, 50:2447-2454.
45. Lucas G., Win N., Calvert A., Green A., Griffin E., Bendukidze N., et al. Reducing the incidence of TRALI in the UK: the results of screening for donor leukocyte antibodies and the development of national guidelines. Vox Sang 2011, (e-pub ahead of print). 10.1111/j.1423-0410.2011.01570.x.
46. Funk M.B., Guenay S., Lohmann A., Henseler O., Heiden M., Hanschmann K.M., et al. Benefit of transfusion-related acute lung injury risk-minimization measures - German haemovigilance data (2006-2010). Vox Sang 2012, 102:317-323.
47. Lin Y., Saw C.L., Hannach B., Goldman M. Transfusion-related acute lung injury preventive measures and their impact at Canadian blood services. Transfusion 2012, 52:567-574.
48. Dooren M.C., Ouwehand W.H., Verhoeven A.J., von dem Borne A.E., Kuijpers R.W. Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrate and monocyte-reactive IgG antibodies. Lancet 1998, 352:1601-1602.
49. Yomtovian R., Kline W., Press C., Clay M., Engman H., Hammerschmidt D., et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet 1984, 1:244-246.
50. Van Buren N.L., Stroncek D.F., Clay M.E., McCullough J., Dalmasso A.P. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990, 30:42-45.
51. Nicolle A.L., Chapman C.E., Carter V., Wallis J.P. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med 2004, 14:225-230.
52. Cooling L. Transfusion-related acute lung injury. JAMA 2002, 17(288):315-316.
53. Toy P., Hollis-Perry K.M., Jun J., Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004, 44:1683-1688.
54. Muniz M., Sheldon S., Schuller R.M., Young N.S., Klein H.G., Leitman S.F., et al. Patient-specific transfusion-related acute lung injury. Vox Sang 2008, 94:70-73.
55. Reil A., Keller-Stanislawski B., Günay S., Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008, 95:313-317.
56. Greinacher A., Wesche J., Hammer E., Fürll B., Völker U., Reil A., et al. Characterization of the human neutrophil alloantigen-3a. Nat Med 2010, 16:45-48.
57. Chapman C.E., Stainsby D., Jones H., Love E., Massey E., Win N., et al. Serious hazards of transfusion steering group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009, 49:440-452.
58. Kopko P.M., Holland P.V. Transfusion-related acute lung injury. Br J Haematol 1999, 105:322-329.
59. Kopko P.M., Paglieroni T.G., Popovsky M.A., Muto K.N., MacKenzie M.R., Holland P.V. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 2003, 43:177-184.
60. Sachs U.J. Recent insights into the mechanism of transfusion-related acute lung injury. Curr Opin Hematol 2011, 18:436-442.
61. Maślanka K., Smoleńska-Sym G., Michur H., Wróbel A., Lachert E., Brojer E. Lysophosphatidylcholines: bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp (Warsz) 2012, 60:55-60.
62. Sachs U.J., Weissmann N., Wasel W., Bein G., Berghöfer H., Schilow W., et al. Supernatants from stored leukodepleted packed red blood cells do not regularly exhibit changes in their (lyso-)phosphatidylcholine composition and do not cause TRALI in an ex vivo rat lung model. Vox Sang 2010, 99:456.
63. Vlaar A.P., Hofstra J.J., Levi M., et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology 2010, 113:92-103.
64. Silliman C.C., Moore E.E., Kelher M.R., Khan S.Y., Gellar L., Elzi D.J. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011, 51:2549-2554.
65. Silliman C.C., Bjornsen A.J., Wyman T.H., Kelher M., Allard J., Bieber S., et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003, 43:633-640.
66. Vlaar A.P., Hofstra J.J., Kulik W., van Lenthe H., Nieuwland R., Schultz M.J., et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010, 116:1360-1368.
67. Vlaar A.P., Kulik W., Nieuwland R., Peters C.P., Tool A.T., van Bruggen R., et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011, 51:2358-2366.
68. Khan S.Y., Kelher M.R., Heal J.M., Blumberg N., Boshkov L.K., Phipps R., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006, 108:2455-2462.
69. Tuinman P.R., Gerards M.C., Jongsma G., Vlaar A.P., Boon L., Juffermans N.P. Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury. Clin Exp Immunol 2011, 165:278-284.
70. Benson A.B., Austin G.L., Berg M., McFann K.K., Thomas S., Ramirez G., et al. Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding. Intensive Care Med 2010, 36:1710-1717.